Sheu S-Y, Handke S, Bröcker-Preuss M, Görges R, Frey U H, Ensinger C, Ofner D, Farid N R, Siffert W, Schmid K W
Institute of Pathology and Neuropathology, University Hospital of Essen, Germany.
J Pathol. 2007 Jan;211(1):60-6. doi: 10.1002/path.2084.
Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism may play a particular role in oncocytic thyroid tumours, which are recognized for their reduced ability to synthesize thyroid-specific proteins and hormones, although they possess an intact thyroid-stimulating hormone receptor-adenylyl cyclase system. Using pyrosequencing, both the genotype distribution and the allele frequency of the C825T polymorphism were investigated in a series of 104 patients with oncocytic thyroid tumours of follicular cell origin [58 adenomas, 41 follicular thyroid carcinomas (FTCs), and five papillary thyroid carcinomas (PTCs)]; the results were compared with those obtained from 321 age and gender-matched healthy blood donors and a series of 327 non-oncocytic thyroid tumours of follicular cell origin (119 adenomas, 80 FTCs, and 186 PTCs). Analysis of the genotype distribution (comparing oncocytic with non-oncocytic tumours of the present series) revealed a significantly increased odds ratio (OR) for CC versus TT (OR = 4.22; p = 0.011) and CC versus CT (OR = 1.62; p = 0.049) carriers to develop an oncocytic thyroid tumour; ORs to develop an oncocytic thyroid tumour were also increased comparing the genotype distribution between the group of oncocytic tumours and healthy controls for CC versus TT (OR = 3.73; p = 0.017) and CC versus all T carriers (OR = 1.56; p = 0.034). Oncocytic thyroid tumours as a group showed a statistically significant increase of the C-allele frequency when compared with all non-oncocytic tumours (p = 0.0039) as well as healthy blood donors (p = 0.017). The results strongly suggest that the C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours. This polymorphism may thus be considered a (co)factor favouring the development of oncocytic thyroid tumours, although the biological mechanism(s) underlying this association remain obscure.
G蛋白GNB3基因常见的C825T多态性的C等位基因携带者与滤泡性甲状腺腺瘤的发生有关。由于该多态性的C等位基因与较低的信号传导能力有关,因此有人推测C825T多态性是否可能在嗜酸细胞性甲状腺肿瘤中起特殊作用,尽管这些肿瘤具有完整的促甲状腺激素受体 - 腺苷酸环化酶系统,但其合成甲状腺特异性蛋白质和激素的能力降低。采用焦磷酸测序法,对104例滤泡细胞起源的嗜酸细胞性甲状腺肿瘤患者(58例腺瘤、41例滤泡性甲状腺癌(FTC)和5例乳头状甲状腺癌(PTC))进行了C825T多态性的基因型分布和等位基因频率研究;将结果与321名年龄和性别匹配的健康献血者以及327例滤泡细胞起源的非嗜酸细胞性甲状腺肿瘤(119例腺瘤、80例FTC和186例PTC)的结果进行比较。对基因型分布的分析(比较本系列中的嗜酸细胞性肿瘤与非嗜酸细胞性肿瘤)显示,CC与TT携带者(比值比(OR)= 4.22;p = 0.011)以及CC与CT携带者(OR = 1.62;p = 0.049)发生嗜酸细胞性甲状腺肿瘤的OR显著增加;比较嗜酸细胞性肿瘤组与健康对照组之间的基因型分布,CC与TT携带者(OR = 3.73;p = 0.017)以及CC与所有T携带者(OR = 1.56;p = 0.034)发生嗜酸细胞性甲状腺肿瘤的OR也增加。与所有非嗜酸细胞性肿瘤(p = 0.0039)以及健康献血者(p = 0.017)相比,嗜酸细胞性甲状腺肿瘤组的C等位基因频率在统计学上显著增加。结果强烈表明,G蛋白β3亚基的GNB3 C825T多态性的C等位基因与嗜酸细胞性甲状腺肿瘤发生风险增加有关。因此,尽管这种关联背后的生物学机制仍不清楚,但这种多态性可被视为有利于嗜酸细胞性甲状腺肿瘤发生的一个(共同)因素。